Terms: = Kidney tumors AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS
111 results:
1. Immunosuppression and cancer risk in kidney transplant recipients: A retrospective cohort study.
Sapir-Pichhadze R; Laprise C; Beauchamp ME; Kaouache M; Zhang X; Della Vecchia A; Azoulay L; Franco EL; Abrahamowicz M; Nicolau B
Int J Cancer; 2024 Jun; 154(12):2043-2053. PubMed ID: 38345158
[TBL] [Abstract] [Full Text] [Related]
2. Combination therapies in patients with favorable risk metastatic renal cell Carcinoma: A Systematic Review and Meta-Analysis.
Bolek H; Yekedüz E; Ürün Y
Cancer Treat Rev; 2024 Jan; 122():102667. PubMed ID: 38101099
[TBL] [Abstract] [Full Text] [Related]
3. Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis.
Yue Y; Cai X; Lu C; Sechi LA; Solla P; Li S
Front Immunol; 2023; 14():1238312. PubMed ID: 37908350
[TBL] [Abstract] [Full Text] [Related]
4. The Application of CT Radiomics in the Diagnosis of Vein Wall Invasion in Patients With Renal Cell Carcinoma Combined With Tumor Thrombus.
Zhao X; Yan Y; Xie W; Zhao L; Zhang S; Liu J; Liu C; Ma L
Oncologist; 2024 Feb; 29(2):151-158. PubMed ID: 37672362
[TBL] [Abstract] [Full Text] [Related]
5. [Development and validation of a prognostic model for patients with sepsis in intensive care unit].
Jiang Z; Wang H; Wang S; Guan C; Qu Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):800-806. PubMed ID: 37593856
[TBL] [Abstract] [Full Text] [Related]
6. Relationship Between Pretreatment Body Composition and Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line Ipilimumab Plus Nivolumab.
McManus HD; Zhang D; Schwartz FR; Wu Y; Infield J; Ho E; Armstrong AJ; George DJ; Kruse D; Gupta RT; Harrison MR
Clin Genitourin Cancer; 2023 Dec; 21(6):e429-e437.e2. PubMed ID: 37271698
[TBL] [Abstract] [Full Text] [Related]
7. Frequency of superscan on bone scintigraphy: A systematic review.
Kovacsne A; Kozon I; Bentestuen M; Zacho HD
Clin Physiol Funct Imaging; 2023 Sep; 43(5):297-304. PubMed ID: 37070619
[TBL] [Abstract] [Full Text] [Related]
8. Risk of Secondary Malignancies in Hematopoietic Stem Cell Transplantation Recipients: A Nationwide Population-Based Study in Taiwan.
Liu HL; Chen YH; Chung CH; Wu GJ; Tsao CH; Sun CA; Chien WC; Hung CT
Balkan Med J; 2023 Mar; 40(2):131-138. PubMed ID: 36804217
[TBL] [Abstract] [Full Text] [Related]
9. Significantly elevated serum human epididymis protein-4 in chronic kidney disease patients without ovarian cancer: A large-scale retrospective study.
Yan S; Lin Y; Tian X
J Clin Lab Anal; 2023 Apr; 37(4):e24847. PubMed ID: 36755361
[TBL] [Abstract] [Full Text] [Related]
10. Citrus fruit intake and incidence of renal cell carcinoma: A meta-analysis of observational studies.
Sheng T; Shen RL; Shao H; Ma TH
Asia Pac J Clin Oncol; 2024 Apr; 20(2):143-151. PubMed ID: 36658686
[TBL] [Abstract] [Full Text] [Related]
11. 5α-Reductase Inhibitors and Risk of kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study.
Doherty N; Cardwell CR; Murchie P; Hill C; Azoulay L; Hicks B
Cancer Epidemiol Biomarkers Prev; 2023 Mar; 32(3):428-434. PubMed ID: 36634196
[TBL] [Abstract] [Full Text] [Related]
12. Malignancy risk in kidney transplant recipients exposed to immunosuppression pre-transplant for the treatment of glomerulonephritis.
Massicotte-Azarniouch D; Detwiler RK; Hu Y; Falk RJ; Saha MK; Hogan SL; Derebail VK
Nephrol Dial Transplant; 2023 Aug; 38(9):2009-2018. PubMed ID: 36549661
[TBL] [Abstract] [Full Text] [Related]
13. Recurrence pattern in localized RCC: results from a European multicenter database (RECUR).
Fallara G; Larcher A; Dabestani S; Fossati N; Järvinen P; Nisen H; Gudmundsson E; Lam TB; Marconi L; Fernandéz-Pello S; Meijer RP; Volpe A; Beisland C; Klatte T; Stewart GD; Bensalah K; Ljungberg B; Bertini R; Montorsi F; Bex A; Capitanio U
Urol Oncol; 2022 Nov; 40(11):494.e11-494.e17. PubMed ID: 36127233
[TBL] [Abstract] [Full Text] [Related]
14. Stereotactic Body Radiotherapy for Renal Cell Carcinoma: Oncological and Renal Function Outcomes.
Glicksman RM; Cheung P; Korol R; Niglas M; Nusrat H; Erler D; Vesprini D; Swaminath A; Davidson M; Zhang L; Chu W
Clin Oncol (R Coll Radiol); 2023 Jan; 35(1):20-28. PubMed ID: 35948465
[TBL] [Abstract] [Full Text] [Related]
15. Enrichment of Tumor-Infiltrating B Cells in Group 4 Medulloblastoma in Children.
Wu KS; Jian TY; Sung SY; Hsieh CL; Huang MH; Fang CL; Wong TT; Lin YL
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563678
[TBL] [Abstract] [Full Text] [Related]
16. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
Liu S; Feng C; Liu C; Wang Z
Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
[TBL] [Abstract] [Full Text] [Related]
17. Clinical laboratory tests associated with survival in patients with metastatic renal cell carcinoma: A Laboratory Wide Association Study (LWAS).
Velaer K; Thomas IC; Yang J; Kapphahn K; Metzner TJ; Golla A; Hoerner CR; Fan AC; Master V; Chertow GM; Brooks JD; Patel CJ; Desai M; Leppert JT
Urol Oncol; 2022 Jan; 40(1):12.e23-12.e30. PubMed ID: 34580027
[TBL] [Abstract] [Full Text] [Related]
18. Low KIBRA Expression Is Associated with Poor Prognosis in Patients with Triple-Negative Breast Cancer.
Kim SW; Chu J; Do SI; Na K
Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441043
[No Abstract] [Full Text] [Related]
19. Impact of Concomitant Cardiovascular Medication on Survival of Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib or Pazopanib in the First Line.
Fiala O; Ostašov P; Rozsypalová A; Hora M; Šorejs O; Šustr J; Bendová B; Trávníček I; Filipovský J; Fínek J; Büchler T
Target Oncol; 2021 Sep; 16(5):643-652. PubMed ID: 34363554
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
Barth DA; Sareban N; Lindner AK; Daller LAJ; Matzhold EM; Hutterer G; Smolle M; Mischinger J; Riedl JM; Seles M; Mannweiler S; Bauernhofer T; Pummer K; Pichler R; Zigeuner R; Schlenke P; Pichler M
Urol Oncol; 2021 Oct; 39(10):736.e9-736.e16. PubMed ID: 34247906
[TBL] [Abstract] [Full Text] [Related]
[Next]
